These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24465544)

  • 41. Polymorphisms in the base excision repair pathway modulate prognosis of platinum-based chemotherapy in advanced non-small cell lung cancer.
    Zhao W; Hu L; Xu J; Shen H; Hu Z; Ma H; Shu Y; Shao Y; Yin Y
    Cancer Chemother Pharmacol; 2013 May; 71(5):1287-95. PubMed ID: 23479135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. No association between XRCC1 genetic polymorphisms and differentiated thyroid carcinoma risk: a meta-analysis.
    Li C; Xiang X; Zhou Y
    Mol Biol Rep; 2014 Nov; 41(11):7613-21. PubMed ID: 25086624
    [TBL] [Abstract][Full Text] [Related]  

  • 43. BRCA1 and XRCC1 polymorphisms associated with survival in advanced gastric cancer treated with taxane and cisplatin.
    Shim HJ; Yun JY; Hwang JE; Bae WK; Cho SH; Lee JH; Kim HN; Shin MH; Kweon SS; Lee JH; Kim HJ; Chung IJ
    Cancer Sci; 2010 May; 101(5):1247-54. PubMed ID: 20331623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis.
    Chen B; Zhou Y; Yang P; Wu XT
    Mol Biol Rep; 2012 Feb; 39(2):1305-13. PubMed ID: 21604176
    [TBL] [Abstract][Full Text] [Related]  

  • 45. XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis.
    Zhang Y; Wang Y; Wu J; Li LJ
    Tumour Biol; 2013 Aug; 34(4):2321-7. PubMed ID: 23681796
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy.
    Yuan Z; Li J; Hu R; Jiao Y; Han Y; Weng Q
    Sci Rep; 2015 Nov; 5():16482. PubMed ID: 26585370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
    Huang ZH; Hua D; Du X
    Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of the Arg194Trp and the Arg399Gln polymorphisms of the XRCC1 gene with risk occurrence and the response to adjuvant therapy among Polish women with breast cancer.
    Przybylowska-Sygut K; Stanczyk M; Kusinska R; Kordek R; Majsterek I
    Clin Breast Cancer; 2013 Feb; 13(1):61-8. PubMed ID: 23103366
    [TBL] [Abstract][Full Text] [Related]  

  • 49. XRCC1 Arg194Trp and Arg280His polymorphisms increase bladder cancer risk in Asian population: evidence from a meta-analysis.
    Fang Z; Chen F; Wang X; Yi S; Chen W; Ye G
    PLoS One; 2013; 8(5):e64001. PubMed ID: 23704969
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Association of XRCC1 gene polymorphisms with the survival and clinicopathological characteristics of gastric cancer.
    Zhang Y; Wang M; Gu D; Wu D; Zhang X; Gong W; Tan Y; Zhou J; Wu X; Tang C; Zhang Z; Chen J
    DNA Cell Biol; 2013 Mar; 32(3):111-8. PubMed ID: 23425027
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between the XRCC1 polymorphisms and glioma risk: a meta-analysis of case-control studies.
    Jiang L; Fang X; Bao Y; Zhou JY; Shen XY; Ding MH; Chen Y; Hu GH; Lu YC
    PLoS One; 2013; 8(1):e55597. PubMed ID: 23383237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymorphism of XRCC1 predicts overall survival of gastric cancer patients receiving oxaliplatin-based chemotherapy in Chinese population.
    Liu B; Wei J; Zou Z; Qian X; Nakamura T; Zhang W; Ding Y; Feng J; Yu L
    Eur J Hum Genet; 2007 Oct; 15(10):1049-53. PubMed ID: 17593927
    [TBL] [Abstract][Full Text] [Related]  

  • 53. GSTP1 Ile105Val and XRCC1 Arg399Gln gene polymorphisms contribute to the clinical outcome of patients with advanced non-small cell lung cancer.
    Bu L; Zhang LB; Mao X; Wang P
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323109
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association between XRCC1 polymorphisms and the risk of cervical cancer: a meta-analysis based on 4895 subjects.
    Zeng X; Zhang Y; Yue T; Zhang T; Wang J; Xue Y; An R
    Oncotarget; 2017 Jan; 8(2):2249-2260. PubMed ID: 27903984
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Quantitative assessment of the associations between XRCC1 polymorphisms and bladder cancer risk.
    Mao Y; Xu X; Lin Y; Chen H; Wu J; Hu Z; Zhu Y; Xu X; Xie L
    World J Surg Oncol; 2013 Mar; 11():58. PubMed ID: 23496911
    [TBL] [Abstract][Full Text] [Related]  

  • 56. DNA repair polymorphisms and treatment outcomes of patients with malignant mesothelioma treated with gemcitabine-platinum combination chemotherapy.
    Erčulj N; Kovač V; Hmeljak J; Franko A; Dodič-Fikfak M; Dolžan V
    J Thorac Oncol; 2012 Oct; 7(10):1609-17. PubMed ID: 22982660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA repair gene associated with clinical outcome of epithelial ovarian cancer treated with platinum-based chemotherapy.
    Kang S; Sun HY; Zhou RM; Wang N; Hu P; Li Y
    Asian Pac J Cancer Prev; 2013; 14(2):941-6. PubMed ID: 23621265
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Predictive values of platinum-related gene polymorphisms in gastric cancer patients on oxaliplatin-based adjuvant chemotherapy].
    Liu YP; Ling Y; Zhang YP; Liu BR
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):256-9. PubMed ID: 21418871
    [TBL] [Abstract][Full Text] [Related]  

  • 59. X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis.
    Wang L; Yin F; Xu X; Hu X; Zhao D
    PLoS One; 2012; 7(4):e34897. PubMed ID: 22529951
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of XRCC1 gene polymorphisms in non-small cell lung cancer cisplatin-based chemotherapy, and their effect on clinical and pathological characteristics.
    Liu HF; Liu JS; Deng JH; Wu RR
    Genet Mol Res; 2016 Dec; 15(4):. PubMed ID: 28081275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.